实用肿瘤学杂志
實用腫瘤學雜誌
실용종류학잡지
JOURNAL OF PRACTICAL ONCOLOGY
2015年
3期
239-244
,共6页
王新玲%赵娟%吴杨佳子%吕慧敏
王新玲%趙娟%吳楊佳子%呂慧敏
왕신령%조연%오양가자%려혜민
重组人纤维连接蛋白%细胞因子诱导的杀伤细胞%增殖%杀伤活性
重組人纖維連接蛋白%細胞因子誘導的殺傷細胞%增殖%殺傷活性
중조인섬유련접단백%세포인자유도적살상세포%증식%살상활성
RetroNectin%CIK%Proliferation%Cytotoxicity
目的:研究并探讨重组人纤维连接蛋白( RetroNectin , RN )对细胞因子诱导的杀伤细胞( CIK)增殖、免疫特性及对人类K562、LOVO细胞杀伤活性的影响。方法提取患者外周血单个核细胞,标本分为四组,对照组( CIK组):按常规方法诱导CIK增殖;C-CIK组:提前通过CD3 Ab包被诱导;R-CIK组:提前通过RetroNectin包被诱导;R+C-CIK组:提前通过RetroNectin及CD3 Ab包被诱导,记录各组免疫效应细胞不同时间段的增殖情况。流式细胞术检测各组细胞不同时间段的免疫表型变化;并用LDH法检测各组细胞对肿瘤细胞K562、LOVO杀伤活性。结果 R+C-CIK组细胞增殖倍数高于其他三组,差异有统计学意义( P<0.05);R+C-CIK组及R-CIK组的CD3+CD56+双阳性细胞所占百分比较C-CIK及CIK组高,d12和d15时有统计学差异(P<0.05);在效靶比20∶1和40∶1时,R+C-CIK及R-CIK组对K562的杀伤活性高于C-CIK及CIK组,杀伤活性有统计学差异(P<0.05),R+C-CIK组、R-CIK组及C-CIK组细胞对结肠癌细胞系LOVO的杀伤活性高于CIK 组,有统计学差异( P<0.05)。结论 RetroNectin联合抗CD3MAb包被技术应用于CIK体外培养可以获得增殖率和活性更高的免疫活性细胞,是值得临床推荐的一种有效的培养方法。
目的:研究併探討重組人纖維連接蛋白( RetroNectin , RN )對細胞因子誘導的殺傷細胞( CIK)增殖、免疫特性及對人類K562、LOVO細胞殺傷活性的影響。方法提取患者外週血單箇覈細胞,標本分為四組,對照組( CIK組):按常規方法誘導CIK增殖;C-CIK組:提前通過CD3 Ab包被誘導;R-CIK組:提前通過RetroNectin包被誘導;R+C-CIK組:提前通過RetroNectin及CD3 Ab包被誘導,記錄各組免疫效應細胞不同時間段的增殖情況。流式細胞術檢測各組細胞不同時間段的免疫錶型變化;併用LDH法檢測各組細胞對腫瘤細胞K562、LOVO殺傷活性。結果 R+C-CIK組細胞增殖倍數高于其他三組,差異有統計學意義( P<0.05);R+C-CIK組及R-CIK組的CD3+CD56+雙暘性細胞所佔百分比較C-CIK及CIK組高,d12和d15時有統計學差異(P<0.05);在效靶比20∶1和40∶1時,R+C-CIK及R-CIK組對K562的殺傷活性高于C-CIK及CIK組,殺傷活性有統計學差異(P<0.05),R+C-CIK組、R-CIK組及C-CIK組細胞對結腸癌細胞繫LOVO的殺傷活性高于CIK 組,有統計學差異( P<0.05)。結論 RetroNectin聯閤抗CD3MAb包被技術應用于CIK體外培養可以穫得增殖率和活性更高的免疫活性細胞,是值得臨床推薦的一種有效的培養方法。
목적:연구병탐토중조인섬유련접단백( RetroNectin , RN )대세포인자유도적살상세포( CIK)증식、면역특성급대인류K562、LOVO세포살상활성적영향。방법제취환자외주혈단개핵세포,표본분위사조,대조조( CIK조):안상규방법유도CIK증식;C-CIK조:제전통과CD3 Ab포피유도;R-CIK조:제전통과RetroNectin포피유도;R+C-CIK조:제전통과RetroNectin급CD3 Ab포피유도,기록각조면역효응세포불동시간단적증식정황。류식세포술검측각조세포불동시간단적면역표형변화;병용LDH법검측각조세포대종류세포K562、LOVO살상활성。결과 R+C-CIK조세포증식배수고우기타삼조,차이유통계학의의( P<0.05);R+C-CIK조급R-CIK조적CD3+CD56+쌍양성세포소점백분비교C-CIK급CIK조고,d12화d15시유통계학차이(P<0.05);재효파비20∶1화40∶1시,R+C-CIK급R-CIK조대K562적살상활성고우C-CIK급CIK조,살상활성유통계학차이(P<0.05),R+C-CIK조、R-CIK조급C-CIK조세포대결장암세포계LOVO적살상활성고우CIK 조,유통계학차이( P<0.05)。결론 RetroNectin연합항CD3MAb포피기술응용우CIK체외배양가이획득증식솔화활성경고적면역활성세포,시치득림상추천적일충유효적배양방법。
Objective To investigate the recombinant human fibronectin (RetroNectin,RN)on prolifera-tion,immunological characteristics and cytotoxicity of cytokine -induced killer cells ( CIK) .Methods Peripheral blood mononuclear cells(PBMCs)were cultured in vitro by precoating with RetroNectin (R-CIK group),CD3Ab (C-CIK group),RetroNectin combined with CD3Ab(R+C-CIK group)and traditional method(CIK group) were to generate CIK.The changes of growth rate,characterization,cytotoxicity and apoptosis of CIK were deter-mined by cell counting ,LDH assay and flow cytometry respectively .Results R+C-CIK cell showed a higher proliferation rate than other three groups .The difference was statistically significant (P<0.05);The percentage of CD3/CD56 double positive cells in R +C-CIK and R-CIK group had a higher proportion than those in C -CIK and CIK group at day12 and day15(P<0.05);Cytotoxicity of CIK towards K562 cells in R+C-CIK group and R-CIK group were significantly higher than that in C -CIK and CIK group ,when effector-to-target ratio was 20∶1 and 40∶1(P<0.05).We also found that the cytotoxicity of CIK towards LOVO cells in R +C-CIK group and R-CIK group were higher than that in C -CIK group and CIK group(P<0.05).Conclusion RetroNectin and Anti-CD3-MAb synergistically promote antitumor efficiency of CIKs by increasing proliferation and cyto-toxicity.